Unfolding type gastroretentive film of cinnarizine based on ethyl cellulose and hydroxypropylmethyl cellulose

International Journal of Biological Macromolecules

Volumn 64, Issue , 2014, Pages 347-352

  Verma, Shakuntla ^a   Nagpal, Kalpana ^b   Singh, S K ^c   Mishra, D N ^c  

^a Jan Nayak Ch Devi Lal Memorial College of Pharmacy   (India)

^b LOVELY PROFESSIONAL UNIVERSITY   (India)

^c GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Gastroretentive dosage form; Hydroxypropyl cellulose, Ethyl cellulose

Indexed keywords

CINNARIZINE; ETHYL CELLULOSE; GELATIN; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG MIXTURE; GASTROINTESTINAL TRACT; REACTION OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; TENSILE STRENGTH;

GASTRORETENTIVE DOSAGE FORM; HYDROXYPROPYL CELLULOSE, ETHYL CELLULOSE;

CELLULOSE; CINNARIZINE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; KINETICS; MECHANICAL PHENOMENA; METHYLCELLULOSE; POLYMERS;

EID: 84891914658     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.12.030     Document Type: Article

References (24)

1. Yeole P.G., Khan S., Patel V.F. Indian J. Pharm. Sci. 2005, 67:265-272.
2. Singh B.N., Kim K.H. J. Control. Release 2000, 63:235-259.
3. Moes A.J. Crit. Rev. Ther. Drug Carrier Syst. 1993, 10:143-195.
4. Oth M., Franz M., Timmermans J., Moes A. Pharm. Res. 1992, 9:298-302.
5. Sato Y., Kawashima Y., Takeuchi H., Yamamoto H. J. Control. Release 2003, 93:39-47.
6. Cargill R., Engle K., Gardner C.R., Porter P.A., Sparer R.V., Fix J.A. Pharm. Res. 1989, 6:506-509.
7. Hoffmana A., Klausnera E.A., Lavy E., Friedmana M. J. Control. Release 2003, 90:143-162.
8. Washington N., Washington C., Wilson C.G. Physiological Pharmaceutics 2001, Taylor & Francis, New York. 2nd ed.
9. Rubinstein A., Li V.H.K., Gruber P., Robinson J.R. Gastrointestinal-physiological variables affecting the performance of oral sustained release dosage forms. Oral Sustained Release Formulation Design and Evaluation 1988, 125-156. Pergamon Press, New York. A. Yacobi, E. Halperin-Walega (Eds.).
10. Ehrlein H.J. Am. J. Physiol. 1988, 254:650-657.
11. Leong K.W., Langer R. Adv. Drug Deliv. Rev. 1987, 1:199-233.
12. Klausner E.A., Lavy E., Friedman M., Hoffman A. Expandable gastroretentive dosage forms. J. Control. Rel. 2003, 90:143-162.
13. Demirel M., Yajan Y., Kalava B.S. Turk. J. Pharm. Sci. 2005, 2:51-62.
14. Arieli R., Shupak A., Shachal B., Shenedrey A., Ertracht O., Rashkovan G. Undersea Hyperbar. Med. 1999, 26:105-109.
15. Barrett R.J., Zolov B. J. Maine Med. Assoc. 1960, 51:454-457.
16. Towse G. J. Laryngol. Otol. 1980, 94:1009-1015.
17. Cilureo F., Cupone I., Minghtti P., Selmin F., Montanari L. Eur. J. Pharma. Biopharm. 2008, 1-17.
18. Mundada A., Satturwar P., Fulzele S., Joshi S., Dorle A. Iran. J. Pharm. Res. 2011, 10:35-42.
19. Dixit R.P., Puthli S.P. J. Control. Release 2009, 139:94-107.
20. Arora P., Biswajit M. J. Pharm. Sci. 2002, 91:2076-2089.
21. Udhumansha Reddy M.V.S., Kumaresan R., Ahmad F.J., Khar R.K. AAPS PharmSciTech. 2007, 8:1-8.
22. Mittal A., Sara U.S., Ali A. Pharm. Acta 2009, 59:383-393.
23. Costa P., Loba J.M.S. Eur. J. Pharm. Sci. 2001, 13:123-133.
24. Preechagoon D., Sumyai V., Tontisirin K., Aumpon S., Pongjanyakul T. J. Pharm. Sci. 2005, 8:362-369.